Related Experiment Video
Updated: Apr 13, 2026

Quantitative Assessment of Human Neutrophil Migration Across a Cultured Bladder Epithelium
Published on: November 7, 2013
MFG-E8 inhibits neutrophil migration through αvβ₃-integrin-dependent MAP kinase activation
Monowar Aziz1, Weng-Lang Yang1, Lana M Corbo1
1Center for Translational Research, The Feinstein Institute for Medical Research and Department of Surgery, Hofstra North Shore‑LIJ School of Medicine, Manhasset, NY, USA.
Abstract:
We have previously demonstrated the involvement of milk fat globule-epidermal growth factor-factor 8 (MFG‑E8) in reducing neutrophil infiltration in a murine model of acute lung injury (ALI). In the present study, we aimed to delineate the mechanisms through which MFG‑E8 attenuates neutrophil migration. Recombinant human MFG‑E8 (rhMFG‑E8) was expressed and purified in our facility. The human differentiated neutrophil cell line, dHL‑60, was treated with rhMFG‑E8 and cell migration assay was performed in a Boyden chamber using recombinant interleukin‑8 (IL‑8) as the chemoattractant. Surface CXCR2 and intracellular G protein‑coupled receptor kinase 2 (GRK2) levels were evaluated by flow cytometry or western blot analysis. The levels of mitogen‑activated protein (MAP) kinases were determined by western blot analysis. Treatment with rhMFG‑E8 resulted in a significant inhibition of dHL‑60 cell migration in a dose‑dependent manner. There was a 46% decrease in CXCR2 expression in the rhMFG‑E8‑treated dHL‑60 cells, which was associated with a 32% increase in GRK2 expression. In the dHL‑60 cells, treatment with rhMFG‑E8 promoted the phosphorylation of p38 and extracellular signal-regulated kinase (ERK) within 10‑30 min. The use of SB203580, a p38 inhibitor, and PD98059, an ERK inhibitor, resulted in the restoration of dHL‑60 cell migration which was significantly inhibited treatment with rhMFG‑E8. Furthermore, blocking the MFG‑E8 receptors, αvβ3/αvβ5‑integrins, by anti‑αv‑integrin neutralizing antibody (Ab) inhibited the activation of p38 and ERK, and reversed the rhMFG‑E8‑induced inhibition of dHL‑60 cell migration. Finally, treatment of the dHL‑60 cells with SB203580 and PD98059 neutralized the rhMFG‑E8‑induced downregulation of CXCR2 expression and upregulation of GRK2 expression, as well as the inhibitory effects on cell migration. Our findings reveal a novel mechanism of action of MFG‑E8 through which it inhibits neutrophil migration through αvβ3-integrin-dependent MAP kinase activation.
Insights
Milk fat globule-epidermal growth factor-factor 8 (MFG-E8) inhibits neutrophil migration by downregulating CXCR2 and upregulating GRK2 via αvβ3-integrin-dependent MAP kinase activation, offering a novel therapeutic target for acute lung injury.
Area of Science:
- Immunology
- Cell Biology
- Molecular Medicine
Background:
- Milk fat globule-epidermal growth factor-factor 8 (MFG-E8) has a known role in reducing neutrophil infiltration in acute lung injury (ALI).
- The precise mechanisms by which MFG-E8 modulates neutrophil migration remain to be fully elucidated.
Purpose of the Study:
- To investigate the molecular mechanisms underlying MFG-E8's inhibitory effect on neutrophil migration.
- To explore the role of specific signaling pathways, including MAP kinases and integrin receptors, in MFG-E8-mediated neutrophil modulation.
Main Methods:
- Recombinant human MFG-E8 (rhMFG-E8) was used to treat differentiated human neutrophil cell lines (dHL-60).
- Cell migration assays were performed using IL-8 as a chemoattractant.
- Flow cytometry and western blotting were employed to assess surface CXCR2, intracellular GRK2, and MAP kinase activation (p38, ERK). Integrin receptor involvement was tested using neutralizing antibodies.
Main Results:
- rhMFG-E8 significantly inhibited dHL-60 cell migration in a dose-dependent manner.
- Treatment with rhMFG-E8 led to decreased CXCR2 and increased GRK2 expression, alongside enhanced phosphorylation of p38 and ERK MAP kinases.
- Inhibition of p38/ERK pathways or blocking of αvβ3/αvβ5-integrins reversed the inhibitory effects of rhMFG-E8 on neutrophil migration and receptor expression.
Conclusions:
- MFG-E8 inhibits neutrophil migration by activating αvβ3-integrin-dependent MAP kinase signaling pathways.
- This mechanism involves the downregulation of CXCR2 and upregulation of GRK2, providing novel insights into MFG-E8's anti-inflammatory actions.
- These findings highlight MFG-E8 as a potential therapeutic agent for inflammatory conditions characterized by excessive neutrophil infiltration, such as ALI.
More Related Videos
10:43Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
11:22Quantitative In vitro Assay to Measure Neutrophil Adhesion to Activated Primary Human Microvascular Endothelial Cells under Static Conditions
Published on: August 23, 2013
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Cell Migration
MAPK Signaling Cascades
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...